Citation: | Working Group of 2019 Novel Coronavirus, Peking Union Medical College Hospital. Diagnosis and Clinical Management of 2019 Novel Coronavirus(2019-nCoV) Infection: An Operational Recommendation of Peking Union Medical College Hospital(V2.0)[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(6): 672-675. DOI: 10.3969/j.issn.1674-9081.20200022 |
[1] |
国家卫生健康委员会办公厅.新型冠状病毒感染的肺炎诊疗方案(试行第三版)[EB/OL]. (2020-01-23).http://www.nhc.gov.cn/yzygj/s7653p/202001/f492c9153ea9437bb587ce2f-fcbee1fa/files/39e7578d85964dbe81117736dd789d8f.pdf.
|
[2] |
World Health Organization.Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection issuspected[EB/OL].https://www.who.int/internal-publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.
|
[3] |
Li TS, Qiu ZF, Han Y, et al. Rapid loss of both CD4 and CD8 T lymphocyte subsets during the acute phase of severe acute respiratory syndrome[J]. Chin Med J, 2003, 116:985-987.
|
[4] |
李太生, 邱志峰, 韩扬, 等.严重急性呼吸综合症急性期T淋巴细胞亚群异常改变[J].中华检验医学杂志, 2003, 26:297-299.
|
[5] |
耿陶然, 韩扬, 李太生, 等.重症流感患者T淋巴细胞与预后研究[J].中华内科杂志, 2020, 59:200-206.
|
[6] |
Mori I, Parizot C, Dorgham K, et al. Prominent plasma-cytosis following intravenous immunoglobulin correlates with clinical improvement in Guillain-Barré syndrome[J]. PLoS One, 2008, 3:e2109.
|
[7] |
Hemming VG. Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases[J].Clin Diagn Lab Immunol, 2001, 8:859-863.
|